UA38773U - Method for treating patients with arterial hypertension and syndrome of insulin resistance - Google Patents

Method for treating patients with arterial hypertension and syndrome of insulin resistance

Info

Publication number
UA38773U
UA38773U UAU200501412U UAU200501412U UA38773U UA 38773 U UA38773 U UA 38773U UA U200501412 U UAU200501412 U UA U200501412U UA U200501412 U UAU200501412 U UA U200501412U UA 38773 U UA38773 U UA 38773U
Authority
UA
Ukraine
Prior art keywords
syndrome
insulin resistance
treating patients
arterial hypertension
imidasolin
Prior art date
Application number
UAU200501412U
Other languages
Russian (ru)
Ukrainian (uk)
Inventor
Евгений Михайлович Нейко
Мария Андреевна Оринчак
Ольга Степановна Човганюк
Original Assignee
Евгений Михайлович Нейко
Мария Андреевна Оринчак
Ольга Степановна Човганюк
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Евгений Михайлович Нейко, Мария Андреевна Оринчак, Ольга Степановна Човганюк filed Critical Евгений Михайлович Нейко
Priority to UAU200501412U priority Critical patent/UA38773U/en
Publication of UA38773U publication Critical patent/UA38773U/en

Links

Landscapes

  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

A method for treating patients with the arterial hypertension with the syndrome of insulin resistance comprises the combined use of antihypertensive drugs. For correcting the endothelial dysfunction, Enalapril maleate is used as the inhibitor of angiotensin-converting enzyme (20-40 mg, daily). Moxonidin is used as the agonist of imidasolin receptors (0.2 mg once a day). The treatment course lasts 2 months.
UAU200501412U 2005-02-15 2005-02-15 Method for treating patients with arterial hypertension and syndrome of insulin resistance UA38773U (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
UAU200501412U UA38773U (en) 2005-02-15 2005-02-15 Method for treating patients with arterial hypertension and syndrome of insulin resistance

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
UAU200501412U UA38773U (en) 2005-02-15 2005-02-15 Method for treating patients with arterial hypertension and syndrome of insulin resistance

Publications (1)

Publication Number Publication Date
UA38773U true UA38773U (en) 2009-01-12

Family

ID=50558690

Family Applications (1)

Application Number Title Priority Date Filing Date
UAU200501412U UA38773U (en) 2005-02-15 2005-02-15 Method for treating patients with arterial hypertension and syndrome of insulin resistance

Country Status (1)

Country Link
UA (1) UA38773U (en)

Similar Documents

Publication Publication Date Title
HK1120409A1 (en) Treatment of diseases by subcutaneous administration of a vegf antagonist
MY143407A (en) Indazole derivatives as inhibitors of hormone sensitive lipase
EA200701159A1 (en) COMBINED MEDICINE INCLUDING TELMISARTAN AND HYDROCHLORTHIAZIDE
TW200733971A (en) CGRP peptide antagonists and conjugates
CY1106879T1 (en) USE OF INHIBITORS OF 3-HYDROXY-3-METHYLOGLUTARYL COenzyme A REDUCTION FOR THE PREPARATION OF A MEDICATION FOR THE TREATMENT OF DIABETIC NEUROPATHY
EP1485381B8 (en) Azolylaminoazine as inhibitors of protein kinases
TW200507869A (en) In vivo indigestible peptide, angiotensin-converting enzyme inhibitor, medicine, and functional food
AU2003220299A1 (en) Azinylaminoazoles as inhibitors of protein kinases
AU2003218215A1 (en) Azolylaminoazines as inhibitors of protein kinases
AU2003220300A1 (en) Compositions useful as inhibitors of protein kinases
TW200833662A (en) 4,5-ring annulated indole derivatives and methods of use thereof
WO2005107747A3 (en) Diindolymethane formulations for the treatment of leiomyomas
EP2526934A3 (en) Inhibitors of bruton's tyrosine kinase
DK2013166T3 (en) N-carbamoylmethyl-4 (R) -phenyl-2-pyrrolidone, process for its preparation and pharmaceutical use
WO2006096173A8 (en) Pharmaceutical compositions and methods for peptide treatment
IL179206A0 (en) Pyrrolylpyrimidine derivatives and pharmaceutical compositions containing the same
MX2007006387A (en) 3-substituted pyridine derivatives as h3 antagonists.
NO20055187L (en) Procedures for the treatment and prevention of lower urinary tract symptoms
MXPA05006399A (en) Methods and dosage forms for reducing heart attacks in a hypertensive individual with a diuretic or a diuretic and an ace inhibitor combination.
NO20052814L (en) Cytomodulatory peptides for the treatment of interstitial cystitis
UA38773U (en) Method for treating patients with arterial hypertension and syndrome of insulin resistance
ATE390148T1 (en) PHARMACEUTICAL COMPOSITION CONTAINING A SELECTIVE I1 IMIDAZOLINE RECEPTOR AGONIST AND AN ANGIOTENSIN II RECEPTOR BLOCKER
MXPA05006408A (en) Deuterated catecholamine derivatives and medicaments comprising said compounds.
NO20073610L (en) Newly substituted thiophenpyrimidinone derivatives as inhibitors of 17β-hydroxysteroid dehydrogenase
EE200400069A (en) Use of citalopram in the preparation of pharmaceutical compositions for the treatment of hypertension